ewsba.se
Oxford Square Capital (OXSQ) advertises 21% yield but distributes 50% more cash than portfolio actually earns.
Oxford Square’s NAV per share fell 27% through 2025, driven by realized losses and CLO equity yield compression to unsustainable levels.
The monthly distribution faces significant risk of another cut as net investment income covers only two-thirds of the current $0.035 payout.
The analyst who called NVIDIA in 2010 just named his top 10 stocks and Oxford Square Capital wasn't one of them. Get them here FREE.
Oxford Square Capital (NASDAQ:OXSQ) advertises a headline yield north of 21%, and the math checks out at the surface. With shares trading around $2 and a monthly distribution of $0.035 per share, the payout looks like a gift. The company behind it is in worse shape than the yield suggests.
Oxford Square is a business development company. It raises capital from shareholders and lends to private middle-market businesses, then passes the interest income through as monthly distributions. Its income comes from two buckets: senior secured debt investments yielding a weighted 14.5% at cost and CLO equity tranches, the riskiest, first-loss slice of collateralized loan obligations.
In the fourth quarter of 2025, debt investments produced $5.3 million and CLO equity contributed $4.3 million. CLO equity is the engine of the high yield, and also the source of the trouble.
The single most important figure for a BDC investor is whether net investment income (NII) covers the distribution. It does not. Q4 NII per share came in at $0.07, which annualizes to roughly $0.28. The annualized distribution is $0.42. Shareholders are receiving about 50% more in cash than the portfolio is actually earning, with the gap effectively a return of capital.
That capital is visibly eroding. NAV per share has fallen every quarter of 2025:
That is a 27% decline in book value over four quarters. Q4 alone shaved off 13%, driven by unrealized depreciation and realized losses. Full-year 2025 realized losses totaled around $17 million.
The CLO equity book is feeling the squeeze. The effective yield on those positions compressed from roughly 10% in Q3 to 9% in Q4, a single-quarter drop. With the 10-year/2-year spread barely positive and the fed funds rate near 4%, leveraged loan defaults are the swing factor for that yield, and Oxford Square already carries one portfolio company on non-accrual at a $5.0 million fair value.
Funding is getting more expensive. The company issued 7.75% Unsecured Notes for net proceeds of about $72.1 million, pushing total liabilities up while shareholders' equity fell 10%. Management has also leaned heavily on at-the-market share sales, issuing roughly 15.9 million new shares across 2025, much of it below NAV. That dilutes per-share NII at exactly the moment per-share NII needs to recover.
Oxford Square already cut its monthly distribution from $0.04 to $0.035 in early 2025, a reduction during 2025. The full-year total return on NAV was -8%, and the market-value total return was -12%. Even after a 11% bounce over the past month, the stock has lagged. Collecting a 21% yield while watching principal compound lower is a losing trade.
The distribution is at meaningful risk. With NII covering only two-thirds of the payout, NAV down sharply, realized losses mounting, CLO yields compressing, and a non-accrual already on the books, another cut is more likely than not if portfolio stress continues into 2026. Oxford Square may suit speculators willing to bet on a credit cycle turn and wider CLO spreads. Income investors focused on a sustainable monthly check have reason to be skeptical of this payout.
This analyst's 2025 picks are up 106% on average. He just named his top 10 stocks to buy in 2026. Get them here FREE.